Erythropoietin in the Evaluation of Treatment Outcomes in Patients with Polytrauma.

Erythropoietin in the Evaluation of Treatment Outcomes in Patients with Polytrauma. Acta Clin Croat. 2017 Dec;56(4):581-587 Authors: Arsenijević V, Šijački A, Marjanović I, Micić D, Nikolić V, Veljković A, Popović P, Stanković S, Jeremić V Abstract Polytrauma is a term describing patients with injuries involving multiple body regions that compromises function of the body and/or organ involved. The aim of the study was to evaluate the potential role of erythropoietin in predicting poorer outcome in trauma patients. This prospective study included 86 patients admitted to the Emergency Center of Serbia due to polytrauma assigned according to Injury Severity Score (ISS). The patients were further evaluated using the Acute Physiology and Chronic Health Evaluation II and Sequential Organ Failure Assessment scores and erythropoietin levels. There was a significant difference among erythropoietin levels at admission, after 48 and 72 hours, and on day 7 of hospital stay, with significantly higher levels in patients with ISS values 49-75. Based on the results, ROC curves were used to identify cut-off levels to predict ISS score with critical clinical course. It was concluded that erythropoietin could be a good marker of injury severity. Further research has to be performed to determine the cut-off values of erythropoietin that are significant for injury severity. PMID: 29590709 [PubMed - in process]
Source: Acta Clinica Croatica - Category: General Medicine Tags: Acta Clin Croat Source Type: research